Prime Therapeutics - Processing Update for amphetamine-dextroamphetamine capsules extended release (i.e., generic Adderall XR®) for Covered Persons of Regence Health Plans

Author: Erica Lawrence/Tuesday, December 19, 2017/Categories: APCI Choice

Effective January 1, 2018 amphetamine-dextroamphetamine capsules extended release (i.e., generic Adderall XR) will become a preferred product. Previously, the branded Adderall XR was the preferred product over the generic for Regence Health Plans. This change will apply to Covered Persons of:

* Regence BlueShield

* Regence BlueShield of Idaho

* Regence BlueCross BlueShield of Utah

* Regence BlueCross BlueShield of Oregon

* Asuris Northwest Health

* BridgeSpan Health

*Please see attached for more information.

Comments are only visible to subscribers.